Seek Returns logo

DXCM vs. SOLV: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at DXCM and SOLV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolDXCMSOLV
Company NameDexCom, Inc.Solventum Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesHealth Care Equipment & Supplies
Market Capitalization32.03 billion USD12.63 billion USD
ExchangeNasdaqGSNYSE
Listing DateApril 14, 2005March 26, 2024
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of DXCM and SOLV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

DXCM vs. SOLV: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolDXCMSOLV
5-Day Price Return2.14%-0.48%
13-Week Price Return-6.08%-3.85%
26-Week Price Return-2.88%-1.96%
52-Week Price Return5.12%22.54%
Month-to-Date Return1.11%2.09%
Year-to-Date Return5.01%10.28%
10-Day Avg. Volume3.24M1.86M
3-Month Avg. Volume3.66M1.00M
3-Month Volatility35.91%23.47%
Beta1.500.85

Profitability

Return on Equity (TTM)

DXCM

25.62%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

In the upper quartile for the Health Care Equipment & Supplies industry, DXCM’s Return on Equity of 25.62% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

SOLV

11.61%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

SOLV’s Return on Equity of 11.61% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

DXCM vs. SOLV: A comparison of their Return on Equity (TTM) against the Health Care Equipment & Supplies industry benchmark.

Net Profit Margin (TTM)

DXCM

13.29%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

A Net Profit Margin of 13.29% places DXCM in the upper quartile for the Health Care Equipment & Supplies industry, signifying strong profitability and more effective cost management than most of its peers.

SOLV

4.52%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s Net Profit Margin of 4.52% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

DXCM vs. SOLV: A comparison of their Net Profit Margin (TTM) against the Health Care Equipment & Supplies industry benchmark.

Operating Profit Margin (TTM)

DXCM

15.98%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

DXCM’s Operating Profit Margin of 15.98% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

SOLV

9.26%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

SOLV’s Operating Profit Margin of 9.26% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

DXCM vs. SOLV: A comparison of their Operating Profit Margin (TTM) against the Health Care Equipment & Supplies industry benchmark.

Profitability at a Glance

SymbolDXCMSOLV
Return on Equity (TTM)25.62%11.61%
Return on Assets (TTM)8.49%2.58%
Net Profit Margin (TTM)13.29%4.52%
Operating Profit Margin (TTM)15.98%9.26%
Gross Profit Margin (TTM)60.01%54.65%

Financial Strength

Current Ratio (MRQ)

DXCM

1.52

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

DXCM’s Current Ratio of 1.52 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.

SOLV

1.22

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

SOLV’s Current Ratio of 1.22 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

DXCM vs. SOLV: A comparison of their Current Ratio (MRQ) against the Health Care Equipment & Supplies industry benchmark.

Debt-to-Equity Ratio (MRQ)

DXCM

0.97

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

DXCM’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.97. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

SOLV

2.14

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

With a Debt-to-Equity Ratio of 2.14, SOLV operates with exceptionally high leverage compared to the Health Care Equipment & Supplies industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

DXCM vs. SOLV: A comparison of their Debt-to-Equity Ratio (MRQ) against the Health Care Equipment & Supplies industry benchmark.

Interest Coverage Ratio (TTM)

DXCM

978.00

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

With an Interest Coverage Ratio of 978.00, DXCM demonstrates a superior capacity to service its debt, placing it well above the typical range for the Health Care Equipment & Supplies industry. This stems from either robust earnings or a conservative debt load.

SOLV

2.65

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s Interest Coverage Ratio of 2.65 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

DXCM vs. SOLV: A comparison of their Interest Coverage Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Financial Strength at a Glance

SymbolDXCMSOLV
Current Ratio (MRQ)1.521.22
Quick Ratio (MRQ)1.320.86
Debt-to-Equity Ratio (MRQ)0.972.14
Interest Coverage Ratio (TTM)978.002.65

Growth

Revenue Growth

DXCM vs. SOLV: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

DXCM vs. SOLV: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

DXCM

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

DXCM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

SOLV

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

SOLV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

DXCM vs. SOLV: A comparison of their Dividend Yield (TTM) against the Health Care Equipment & Supplies industry benchmark.

Dividend Payout Ratio (TTM)

DXCM

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

DXCM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

SOLV

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

SOLV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

DXCM vs. SOLV: A comparison of their Dividend Payout Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Dividend at a Glance

SymbolDXCMSOLV
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

DXCM

55.71

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

A P/E Ratio of 55.71 places DXCM in the upper quartile for the Health Care Equipment & Supplies industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

SOLV

33.33

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

SOLV’s P/E Ratio of 33.33 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

DXCM vs. SOLV: A comparison of their Price-to-Earnings Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Price-to-Sales Ratio (TTM)

DXCM

7.40

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

DXCM’s P/S Ratio of 7.40 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

SOLV

1.51

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s P/S Ratio of 1.51 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

DXCM vs. SOLV: A comparison of their Price-to-Sales Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Price-to-Book Ratio (MRQ)

DXCM

13.30

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

At 13.30, DXCM’s P/B Ratio is at an extreme premium to the Health Care Equipment & Supplies industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

SOLV

3.60

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

SOLV’s P/B Ratio of 3.60 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

DXCM vs. SOLV: A comparison of their Price-to-Book Ratio (MRQ) against the Health Care Equipment & Supplies industry benchmark.

Valuation at a Glance

SymbolDXCMSOLV
Price-to-Earnings Ratio (TTM)55.7133.33
Price-to-Sales Ratio (TTM)7.401.51
Price-to-Book Ratio (MRQ)13.303.60
Price-to-Free Cash Flow Ratio (TTM)55.7854.92